General MedicationsINTRATHECALStandard
MPI INDIUM DTPA IN 111
INDIUM IN-111 PENTETATE DISODIUM
Standard Dose
1mCi/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview MPI INDIUM DTPA IN 111 is listed in Drugs@FDA under application 017707 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient INDIUM IN-111 PENTETATE DISODIUM Form and strength INJECTABLE;INTRATHECAL - 1mCi/ML Sponsor GE HEALTHCARE Submission history Latest submission status date: 2016-12-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview MPI INDIUM DTPA IN 111 is listed in Drugs@FDA under application 017707 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient INDIUM IN-111 PENTETATE DISODIUM Form and strength INJECTABLE;INTRATHECAL - 1mCi/ML Sponsor GE HEALTHCARE Submission history Latest submission status date: 2016-12-22 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.